Silencing of CCR2 in myocarditis

European Heart Journal

Volumn 36, Issue 23, 2015, Pages 1478-1488

  Leuschner, Florian ^a,b,c   Courties, Gabriel ^a   Dutta, Partha ^a   Mortensen, Luke J ^a   Gorbatov, Rostic ^a   Sena, Brena ^a   Novobrantseva, Tatiana I ^d   Borodovsky, Anna ^d   Fitzgerald, Kevin ^d   Koteliansky, Victor ^b   Iwamoto, Yoshiko ^a   Bohlender, Marina ^b,c   Meyer, Soeren ^b,c   Lasitschka, Felix ^b   Meder, Benjamin ^b,c   Katus, Hugo A ^b,c   Lin, Charles ^a   Libby, Peter ^e   Swirski, Filip K ^a   Anderson, Daniel G ^b,f,g   Weissleder, Ralph ^a,h   Nahrendorf, Matthias ^a   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^d ALNYLAM PHARMACEUTICALS   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^g Institute for Medical Engineering and Science   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Inflammation; Molecular imaging; Myocarditis; Nanoparticle; SiRNA

Indexed keywords

CHEMOKINE RECEPTOR CCR2; MAGNETIC NANOPARTICLE; MESSENGER RNA; SMALL INTERFERING RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NANOPARTICLE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; FLOW CYTOMETRY; FOLLOW UP; GENE SILENCING; HEART EJECTION FRACTION; HEMATOPOIETIC STEM CELL; HUMAN; LEUKOCYTE MIGRATION; MONOCYTE; MOUSE; MYOCARDITIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RNA INTERFERENCE; VOLUMETRY; ANIMAL; AUTOIMMUNE DISEASES; CELL MOTION; FEMALE; GENETICS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; METABOLISM; PHYSIOLOGY;

ADULT; ANIMALS; AUTOIMMUNE DISEASES; CELL MOVEMENT; CHEMOKINE CCL2; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MICE; MONOCYTES; MYOCARDITIS; NANOPARTICLES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84942429743     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu225     Document Type: Article

References (40)

1. Cooper LTJ. Myocarditis. N Engl J Med 2009;360:1526-1538.
2. Rose NR. Myocarditis: infection versus autoimmunity. J Clin Immunol 2009;29: 730-737.
3. Schultheiss H, Kuhl U, Cooper L. The management of myocarditis. Eur Heart J 2011; 32:2616-2625.
4. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333:269-275.
5. Leuschner F, Katus HA, Kaya Z. Autoimmune myocarditis: past, present and future. J Autoimmun 2009;33:282-289.
6. Afanasyeva M, Georgakopoulos D, Belardi DF, Ramsundar AC, Barin JG, Kass DA, Rose NR. Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function. Am J Pathol 2004;164:807-815.
7. Sagar S, Liu PP, Cooper LT. Myocarditis. Lancet. 2012;379:738-747.
8. Serbina NV, Pamer EG. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 2006;7:311-317.
9. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006;354:610-621.
10. Si Y, Tsou CL, Croft K, Charo IF.CCR2mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice. J Clin Invest 2010;120:1192-1203.
11. Goser S, Ottl R, Brodner A, Dengler TJ, Torzewski J, Egashira K, Rose NR, Katus HA, Kaya Z. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation 2005;112:3400-3407.
12. Leuschner F, Dutta P, Gorbatov R, Novobrantseva TI, Donahoe JS, Courties G, Lee KM, Kim JI, Markmann JF, Marinelli B, Panizzi P, Lee WW, Iwamoto Y, Milstein S, Epstein-Barash H, CantleyW, Wong J, Cortez-Retamozo V, Newton A, Love K, Libby P, Pittet MJ, Swirski FK, Koteliansky V, Langer R, Weissleder R, Anderson DG, Nahrendorf M. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol 2011;29:1005-1010.
13. Love KT, Mahon KP, Levins CG, Whitehead KA, Querbes W, Dorkin JR, Qin J, Cantley W, Qin LL, Racie T, Frank-Kamenetsky M, Yip KN, Alvarez R, Sah DW, de Fougerolles A, Fitzgerald K, Koteliansky V, Akinc A, Langer R, Anderson DG. Lipidlike materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci USA 2010;107: 1864-1869.
14. Akinc A, Zumbuehl A, Goldberg M, Leshchiner ES, BusiniV, Hossain N, Bacallado SA, Nguyen DN, Fuller J, Alvarez R, Borodovsky A, Borland T, Constien R, de Fougerolles A, Dorkin JR, Narayanannair Jayaprakash K, Jayaraman M, John M, Koteliansky V, Manoharan M, Nechev L, Qin J, Racie T, Raitcheva D, Rajeev KG, Sah DW, Soutschek J, Toudjarska I, Vornlocher HP, Zimmermann TS, Langer R, Anderson DG. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol 2008;26:561-569.
15. Gordon S. Targeting a monocyte subset to reduce inflammation. Circ Res 2012;110: 1546-1548.
16. Kaya Z, Goser S, Buss SJ, Leuschner F, Ottl R, Li J, Volkers M, Zittrich S, Pfitzer G, Rose NR, Katus HA. Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis. Circulation 2008;118:2063-2072.
17. Semple SC, Akinc A, Chen J, Sandhu AP, Mui BL, Cho CK, Sah DW, Stebbing D, Crosley EJ, Yaworski E, Hafez IM, Dorkin JR, Qin J, Lam K, Rajeev KG, Wong KF, Jeffs LB, Nechev L, Eisenhardt ML, Jayaraman M, Kazem M, Maier MA, Srinivasulu M, Weinstein MJ, Chen Q, Alvarez R, Barros SA, De S, Klimuk SK, Borland T, Kosovrasti V, Cantley WL, Tam YK, Manoharan M, Ciufolini MA, Tracy MA, de Fougerolles A, MacLachlan I, Cullis PR, Madden TD, Hope MJ. Rational design of cationic lipids for siRNA delivery. Nat Biotechnol 2010;28:172-176.
18. Goser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Ottl R, Zittrich S, Blaudeck N, Hardt SE, Pfitzer G, Rose NR, Katus HA, Kaya Z. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 2006;114:1693-1702.
19. Lo Celso C, Lin CP, Scadden DT. In vivo imaging of transplanted hematopoietic stem and progenitor cells in mouse calvarium bone marrow. Nat Protoc. 2011;6:1-14.
20. Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins C, Iwamoto Y, Thompson B, Carlson A, Heidt T, Majmudar M, Lasitschka F, Etzrodt M, Waterman P, Waring M, Chicoine A, Van Der Laan A, Niessen H, Piek J, Rubin B, Butany J, Stone J, Katus H, Murphy S, Morrow D, Sabatine M, Vinegoni C, Moskowitz M, Pittet M, Libby P, Lin C, Swirski FK, Weissleder R, Nahrendorf M. Myocardial infarction accelerates atherosclerosis. Nature 2012;487:325-329.
21. Nahrendorf M, Sosnovik DE, Waterman P, Swirski FK, Pande AN, Aikawa E, Figueiredo JL, Pittet MJ, Weissleder R. Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct. Circ Res 2007;100:1218-1225.
22. Leuschner F, Nahrendorf M. Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic. Circ Res 2011;108:593-606.
23. Leuschner F, Panizzi P, Chico-Calero I, Lee WW, Ueno T, Cortez-Retamozo V, Waterman P, Gorbatov R, Marinelli B, Iwamoto Y, Chudnovskiy A, Figueiredo JL, Sosnovik DE, Pittet MJ, Swirski FK, Weissleder R, Nahrendorf M. Angiotensinconverting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res 2010;107:1364-1373.
24. Blyszczuk P, Valaperti A, Eriksson U. Future therapeutic strategies in inflammatory cardiomyopathy: insights from the experimental autoimmune myocarditis model. Cardiovasc Hematol Dis Drug Targets 2008;8:313-321.
25. Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 2013;339:161-166.
26. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo JL, Kohler RH, Chudnovskiy A, Waterman P, Aikawa E, Mempel TR, Libby P, Weissleder R, Pittet MJ. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009;325:612-616.
27. Cihakova D, Rose N. Advances in immunology. Adv Immunol. 2008;99:95-114.
28. Parrillo JE, Cunnion RE, Epstein SE, Parker MM, Suffredini AF, Brenner M, Schaer GL, Palmeri ST, Cannon ROr, Alling D et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989;321:1061-1068.
29. Fuse K, Kodama M, Hanawa H, Okura Y, Ito M, Shiono T, Maruyama S, Hirono S, Kato K, Watanabe K, Aizawa Y. Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis. Clin Exp Immunol 2001;124:346-352.
30. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009;27:669-692.
31. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, StarlingRC, Towbin J, Virmani R.The role of end omyocardialbiopsy inthemanagement of cardiovascular disease: A scientific statement from the AmericanHeart Association, the AmericanCollege ofCardiology, and the European SocietyofCardiology. Endorsed by the Heart Failure Society of America and theHeart Failure Association of the European Society of Cardiology. J AmColl Cardiol 2007;50:1914-1931.
32. Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 1989;64:1235-1245.
33. van Heeswijk RB, De Blois J, Kania G, Gonzales C, Blyszczuk P, Stuber M, Eriksson U, Schwitter J. Selective in vivo visualization of immune-cell infiltration in a mouse model of autoimmune myocarditis by fluorine-19 cardiac magnetic resonance. Circ Cardiovasc Imaging 2013;6:277-284.
34. Moon H, Park HE, Kang J, Lee H, Cheong C, Lim YT, Ihm SH, Seung KB, Jaffer FA, Narula J, Chang K, Hong KS. Noninvasive assessment of myocardial inflammation by cardiovascular magnetic resonance in a rat model of experimental autoimmune myocarditis. Circulation 2012;125:2603-2612.
35. Alam SR, Shah AS, Richards J, Lang NN, Barnes G, Joshi N, MacGillivray T, McKillop G, Mirsadraee S, Payne J, Fox KA, Henriksen P, Newby DE, Semple SI. Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: Early clinical experience. Circ Cardiovasc Imaging 2012;5:559-565.
36. Yilmaz A, Dengler MA, van der Kuip H, Yildiz H, Rösch S, Klumpp S, Klingel K, Kandolf R, Helluy X, Hiller KH, Jakob PM, Sechtem U. Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: A human study using a multi-parametric cardiovascular magnetic resonance imaging approach. Eur Heart J 2013;34:462-475.
37. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM. Diseases ESoCWGoMaP. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of CardiologyWorking GrouponMyocardial and Pericardial Diseases. Eur Heart J 2013;34:2636-2648, 2648a-2648d.
38. King KY, Goodell MA. Inflammatory modulation of HSCs: viewing theHSCas a foundation for the immune response. Nat Rev Immunol 2011;11:685-692.
39. Kania G, Blyszczuk P, Stein S, Valaperti A, Germano D, Dirnhofer S, Hunziker L, Matter CM, Eriksson U. Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis. Circ Res 2009;105:462-470.
40. Blyszczuk P, Berthonneche C, Behnke S, Glö nkler M, Moch H, Pedrazzini T, Lüscher TF, Eriksson U, Kania G. Nitric oxide synthase 2 is required for conversion of pro-fibrogenic inflammatoryCD133(+) progenitors into F4/80(+) macrophages in experimental autoimmune myocarditis. Cardiovasc Res 2013;97:219-229.